Epstein Secrets

iews" by Robert W. Winslow and Virginia Winslow. Bull Am Acad Psychiatry Law 2:199-201, 1974. 5. Dietz PE: Review of "Heritage of Excellence: The Johns Hopkins Medical Institutions, 1914-1947" by Thomas B. Turner, Johns Hopkins Magazine 26:6-8, January 1975. 6. Dietz PE: Review of "The Case on Cloud Nine

.P.H., Ph.D. Page 2 Phi Beta Kappa, 1970 Phi Kappa Phi, 1970 A.B. cum laude in Psychology and With Distinction in All Subjects, 1970 1975 M.D. Johns Hopkins University School of Medicine Alpha Omega Alpha, 1975 1975 M.P.H. Johns Hopkins School of Hygiene and Public Health 1984 Ph.D. Johns Hopkins University (Sociology) POSTGRADUA

sting Dr. Nowak's help, EFTA00583237 Vogelstein and the PED designed a mathematical model from the tumorous tissue of 28 colon cancer patients at Johns Hopkins about to embark on a course of panitumumab treatment. Nowak's findings were extraordinary: they showed that even before treatment began, less than .

n of Dr. Bert Vogelstein, the Director of the Ludwig Center for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nowak's help, EFTA00583237 Vogelstein and t

anitumumab. Enlisting Dr. Nowak's help. Vogelstein and the PED designed a mathematical model from the tumorous tissue of 28 colon cancer patients at Johns Hopkins about to embark on a course of panitumumab treatment. Nowak's findings were extraordinary: they showed that even before treatment began, less than .

on of Dr. Ben Vogelstein. the Director of the Ludwig Ccntcr for Cancer Genetics and Therapeutics at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University School of Medicine. Dr. Vogelstein was studying resistance to a colon cancer inhibitor called panitumumab. Enlisting Dr. Nowak's help. Vogelstein and the PED designed